Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 7OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 218Neoplasms 149Prostatic Neoplasms 123Colorectal Neoplasms 98Lung Neoplasms 86Leukemia, Myeloid, Acute 68Pancreatic Neoplasms 67Carcinoma, Non-Small-Cell Lung 66Multiple Myeloma 58Brain Neoplasms 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 50Melanoma 48Glioblastoma 46Ovarian Neoplasms 44Head and Neck Neoplasms 42Carcinoma, Hepatocellular 42Uterine Cervical Neoplasms 40Sarcoma 37Glioma 37Neoplasm Metastasis 36Stomach Neoplasms 33Recurrence 33Lymphoma, Non-Hodgkin 33Hematologic Neoplasms 33Carcinoma, Renal Cell 33Squamous Cell Carcinoma of Head and Neck 32Rectal Neoplasms 31Leukemia 31Esophageal Neoplasms 30Myelodysplastic Syndromes 29

Interventions

Leucovorin 1Irinotecan 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Digestive System Neoplasms × 30 days × Clear all
NCT03303495 2026-06-05

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Sun Yat-sen University

Phase 3 Recruiting
280 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT07603596 2026-05-22

Opioid-free Anesthesia and Postoperative Delirium

Qianfoshan Hospital

Phase 1 Not yet recruiting
174 enrolled
Gastrointestinal

Emergence Delirium, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡